Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy science biotech

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? - 29 days ago
2	Deanna Fox, PharmD Pharmacy Times Former journalist. Now comms exec. Capital Region, New York communications	OTC Case Studies, Pain Management - about 1 month ago OTC Case Studies: Contraception - 2 months ago OTC Case Studies- Smoking Cessation - 5 months ago OTC Case Studies: Winter Colds - 6 months ago OTC Case Studies: Self-Care for Oral Health - 8 months ago Weight Loss: OTC Case Studies - 9 months ago
3	The Conversation Next Web The Heart of Tech ❤️ Amsterdam, The Netherlands technology	AI-powered ‘deep medicine’ could transform healthcare in the NHS - 3 months ago Just One Drug Could Treat America's Top Two Killer Diseases - 7 months ago
4	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way - 4 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Psychedelic Medicine Could Fill Care Gap in Psychiatric Care - 4 months ago
6	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	These four common medicines could help prolong your life - 4 months ago
7	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 4 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more - 5 months ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 5 months ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - 5 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 5 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 5 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 5 months ago STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more - 6 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 7 months ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - 7 months ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - 7 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 8 months ago STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial - 8 months ago STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data - 8 months ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - 9 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 9 months ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - 9 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 10 months ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - 10 months ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - 10 months ago
8	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	Wegovy and Zepbound get primetime treatment - 4 months ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Precision Medicine as 'Next Frontier' for Severe Asthma Treatment - 4 months ago
10	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Madrigal wins first U.S. approval for drug to treat liver disease MASH - 4 months ago STAT+: First medicine developed to treat MASH expected to be approved soon - 5 months ago

Journalists covering Medicine